Lutfiye NBGH
Istanbul, 34300, Turkey (Türkiye)
NCT Number: NCT02568852
Pneumoperitoneum is formed with CO2 during laparoscopic abdominal operations. Effect of pneumoperitoneum on coagulation factors is not well known. In our study the investigators aimed to compare the general anesthesia(GA) and combined spinal-epidural anesthesia (CA) during laparoscopic cholecystectomy(LC) with effect on coagulation factors.
Fifty patients will be randomly assigned to either the Laparoscopic cholecystectomy under Combined anaesthesia (25 patients) or Laparoscopic cholecystectomy under general anaesthesia (25 patients). All patients has symptomatic gall stone disease or polyp of gall bladder.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Istanbul, 34300, Turkey (Türkiye)
Objective of study : The aim of this study was to compare general anesthesia (GA) and combined (epidural and spinal) anesthesia (CA) for laparoscopic cholecystectomy(LC).Laparoscopic cholecystectomies are usually performed under general anesthesia. Studies involving cholecystectomies with regional anesthesia recently published. During regional anesthesia pneumoperitoneum is performed with lower pressure(10mmHg CO2). Patients can not tolerate higher intraabdominally pressure. Thera are very few studies involving the effect of pneumoperitoneum on coagulation factors. In our study the investigators separate the patients into 2 groups. Group1:10 mmHg pressure, laparoscopic cholecystectomy under general anesthesia ; Group2 : 10 mmHg pressure, laparoscopic cholecystectomy under Combined Spinal-Epidural Anesthesia The investigators performed standard conventional laparoscopic cholecystectomy procedure with 10mmHg pressure in both groups. The investigators aimed to investigate Prothrombin Time(PT), activated partial thromboplastin time(aPTT), thrombin time(TT), D-dimer and fibrinogen levels preoperative, postoperative 1st hour and 24th hour respectively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laparoscopic cholecystectomy under 10 mmHg pressure
Laparoscopic cholecystectomy under 10 mmHg pressure
Time frame: up to 2 hours
group1 and group 2(Duration of Operation)
Time frame: pre-operative
A soluble plasma glycoprotein, that is converted by thrombin into fibrin during blood clot formation
Time frame: Post-operative 1 st hour
A soluble plasma glycoprotein, that is converted by thrombin into fibrin during blood clot formation
Time frame: Post-operative 24th hour
A soluble plasma glycoprotein, that is converted by thrombin into fibrin during blood clot formation
Time frame: pre-operative
measures of the extrinsic pathway of coagulation
Time frame: Post-operative 1st hour
measures of the extrinsic pathway of coagulation
Time frame: Post-operative 24th hours
measures of the extrinsic pathway of coagulation
Time frame: pre-operative
A fibrin degradation product (or FDP) present in the blood after a blood clot is degraded by fibrinolysis
Time frame: Post-operative 1st hour
A fibrin degradation product (or FDP) present in the blood after a blood clot is degraded by fibrinolysis
Time frame: Post-operative 24th hours
A fibrin degradation product (or FDP) present in the blood after a blood clot is degraded by fibrinolysis
Time frame: pre-operative
measures of the intrinsic pathway of coagulation
Time frame: Post-operative 1st hour
measures of the intrinsic pathway of coagulation
Time frame: Post-operative 24th hours
measures of the intrinsic pathway of coagulation
Time frame: pre-operative
measures of the extrinsic and intrinsic pathway of coagulation
Time frame: Post-operative 1st hour
measures of the extrinsic and intrinsic pathway of coagulation
Time frame: Post-operative 24th hours
measures of the extrinsic and intrinsic pathway of coagulation
Lütfiye Nuri Burat Government Hospital
Other Gov
Comparison of Coagulation Factors During Laparoscopic Cholecystectomy With General Anesthesia and Spinal-epidural Anesthesia:Prospective Randomized Trials
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02317510
Gall Stone Disease, Pathological Conditions, Anatomical
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02327923
Gall Stone Disease
Dharān, Sunsari District, Nepal
View Trial DetailsNCT02136095
Gall Stone Disease
Hvidovre, Denmark
View Trial DetailsNCT01103570
Biliary Tract Anatomy, Common Bile Duct Stones.
Cairo, Egypt
View Trial Details